Efficacy evaluation of an herbal compound in COVID-19

INTERVENTION: Intervention 1: Intervention group: This group will receive routine treatments for COVID‐19 disease and will receive a suspension of extract of five herbs. Patients will receive a combination consisted of aqueous extract of 10 grams of hyssop leaf, 5 grams of Plantain seed, 10 grams of purslane seed , 10 grams of licorice root and 5 grams of turmeric, orally, in three divided doses daily. The intervention duration is five days. Intervention 2: Control group: This group receive routine treatments for COVID‐19 disease and placebo. Placebo will be given as an oral syrup, three servings a day. For the placebo syrup, a non‐absorbable sweetened drop of stevia (a product from a pharmaceutical company), authorized oral dyes are used to make the color and taste relatively similar to the original drug. CONDITION: COVID‐19. ; COVID‐19 U07.1 PRIMARY OUTCOME: Changing the patient's clinical status in the COVID‐19 clinical classification table. Timepoint: Before and after intervention. Method of measurement: Clinical and Paraclinical Indicators in COVID‐19 Classification Table. SECONDARY OUTCOME: Cell blood count. Timepoint: Before and after the intervention. Method of measurement: Cell conuter. Liver enzymes. Timepoint: Before and after the intervention. Method of measurement: spectrometer. INCLUSION CRITERIA: Hospitalized patients with clinical and CT scan findings strongly suspected of COVID ‐19 Relative stability in cardiovascular status Moderate and severe cases No organ damage